Magic Mushrooms: What They Are, Effects, Risks and the Law in Europe

Magic mushrooms are fungi that contain psilocybin and psilocin, two compounds that change perception, mood and thinking for several hours. Many species produce them; the best known is Psilocybe cubensis, the species in most grow kits. In almost every European country magic mushrooms are a controlled drug in 2026, but the rules for truffles, spores and grow kits differ a lot from one country to the next.

What are magic mushrooms?

Magic mushrooms are the fruiting bodies of fungi that produce psilocybin, mostly species in the genus Psilocybe. The fruiting body is only the visible part. Most of the organism lives as mycelium, a network of fine threads inside soil, dung, wood or, in cultivation, a grain or compost substrate.

A few species you will come across:

  • Psilocybe cubensis: tropical and subtropical, easy to cultivate, and the basis of nearly all grow kits and of the strains in Mondo’s strain library.
  • Psilocybe semilanceata: the liberty cap, a small wild species of European grassland.
  • Psilocybe cyanescens and Psilocybe azurescens: wood-loving species from temperate climates.
  • Psilocybe tampanensis, mexicana and galindoi: species that can form sclerotia, which are sold as magic truffles.

Many psilocybin mushrooms bruise blue when handled. That colour comes from the oxidation of psilocin, but many non-psychoactive and even toxic fungi also stain, so colour says nothing about safety.

Magic mushrooms vs magic truffles: what is the difference?

A magic truffle is not a mushroom but a sclerotium: a hard, compact lump of mycelium that some Psilocybe species form underground as a food and survival store. It contains the same active compounds. Psilocybe cubensis does not form sclerotia, so a cubensis grow kit produces mushrooms only.

The difference sounds academic, but in the Netherlands it is the legal line. The Opium Act names mushrooms, not sclerotia, which is why fresh magic truffles can be sold there while mushrooms cannot. We compare both forms in magic truffles vs magic mushrooms.

A short history

People in Mesoamerica used psilocybin mushrooms in ceremony long before Europeans arrived, and the Mazatec tradition in Oaxaca is the best documented. Western interest began in 1957, when R. Gordon Wasson described a Mazatec mushroom ceremony in Life magazine. A year later the Swiss chemist Albert Hofmann isolated psilocybin and psilocin from Psilocybe mexicana and gave both their names (Hofmann et al., 1958).

Research continued in the 1960s, until psilocybin was placed in Schedule I of the UN Convention on Psychotropic Substances of 1971. Most European drug laws still follow that classification. Clinical research restarted around 2000 and has grown fast since.

How do magic mushrooms work in the brain?

Psilocybin itself is a prodrug: the body converts it into psilocin, and psilocin is what acts in the brain. Psilocin binds mainly to the serotonin 5-HT2A receptor, especially in the cortex, and that activation is regarded as the main driver of the psychedelic effect (Nichols, 2016).

How that receptor activity turns into the experience itself is still being studied. For the chemistry in more detail, read what is psilocybin.

What are the effects and risks?

The effects of magic mushrooms are mainly psychological: altered perception of colour, sound and time, strong emotions, changes in how you think about yourself, and sometimes visual distortions. They last several hours. How someone reacts depends on the person, the amount, and on set and setting: mindset, expectations and the physical and social surroundings. Mushrooms vary in strength, even within one batch, so the same amount can feel very different.

The known risks, as described in research safety guidelines (Johnson et al., 2008) and by public drug information services:

  • A difficult experience. Anxiety, panic, confusion or paranoia, sometimes called a bad trip.
  • Risky behaviour. Accidents happen when judgement and perception are altered, especially near traffic, water or heights.
  • Mental health. People with a personal or family history of psychosis or bipolar disorder run a higher risk of serious psychiatric reactions.
  • Interactions. Combining with alcohol, other drugs or some medicines can make effects less predictable.
  • Wild mushrooms. Picking wild fungi carries a real risk of confusing them with poisonous species. Some lookalikes cause lasting organ damage.
  • Physical effects. Nausea, a raised heart rate and higher blood pressure are common.

Psilocybin is not considered physically addictive, and tolerance builds quickly. That does not make it harmless.

Where to find reliable information

If you have questions about use, risks or someone else’s reaction, contact an official drug information service: Jellinek or DRUGSinfo in the Netherlands, De Druglijn in Belgium, or the EUDA for European data. In an emergency, call 112.

No European country in this overview allows the open sale of psilocybin mushrooms. What does differ is how possession is punished, and how truffles, spores and grow kits are treated. The table below summarises the situation as we verified it in October 2026; “unclear” means we could not confirm it in a primary or authoritative source.

CountryMushroomsTrufflesSporesGrow kitsMain source
NetherlandsIllegal, fresh and dried (Opium Act, List II, since 1 December 2008)Fresh: not covered by the Opium Act; dried: prohibitedNot listed in the Opium ActLegal to sell and possess; mushrooms that grow from them are notOpiumwet; DRUGSinfo; Jellinek
GermanyIllegal (BtMG Anlage I)IllegalProhibited if intended for growing psychoactive mushroomsSame as spores; in practice treated as intended for cultivationBtMG Anlage I; BVerfG 2 BvR 338/09
BelgiumIllegalIllegal, regardless of amountUnclearUnclearDe Druglijn; Infor-Drogues
FranceIllegal (listed as hallucinogenic mushrooms)Illegal (contain psilocybin)UnclearCultivation can be prosecuted as productionArrêté of 22 February 1990; Drogues Info Service
SpainSale can be prosecuted as trafficking; private use is not a crime; public use or possession is finedPsilocybin is controlled; specific status unclearPossession is not an offenceUnclearEnergy Control
ItalyIllegal (Tabella I names fungi of the genera Stropharia, Conocybe and Psilocybe)Illegal (contain psilocybin)Sold as not containing psilocybin; no official confirmation foundUnclearDPR 309/1990, Tabella I
AustriaOffering, supplying, or growing for drug use is a crime; acquisition and possession are not punishable (OGH, 2023)Same rules as mushrooms (psilocybin-containing fungi)Not named in § 27 SMGGrowing is punishable only if done for drug use§ 27 SMG; OGH 13 Os 101/23m
SwitzerlandIllegal (BetmVV-EDI, list d)Contain psilocybin, a prohibited substanceUnclearUnclearBetmVV-EDI; Lenz & Staehelin
CzechiaPossession of a small amount is a misdemeanour, a larger amount a crimeNot named separately; contain psilocybinUnclearCultivation is punishableNZIP (Ministry of Health portal)
PortugalPersonal possession of controlled drugs is an administrative offence (Law 30/2000), not a crime; sale is a crimeNot named separately; contain psilocybinUnclearUnclearLei 30/2000

Status checked in October 2026. Laws change; check the current text before you rely on any line in this table.

A few points the table cannot show:

  • Germany covers not only organisms that contain psilocybin, but also spores and mycelium that are suitable for producing them, when they are intended for intoxication. The Federal Constitutional Court confirmed in 2009 that fungi fall under the law.
  • Austria is the outlier. Its Supreme Court ruled in December 2023 (13 Os 101/23m) that acquiring and possessing psilocybin mushrooms is not punishable, while offering or supplying them to others is.
  • Czechia set the line between a misdemeanour and a crime at more than 40 fruiting bodies, according to the Ministry of Health portal. The Criminal Code was amended from 1 January 2026; we could not confirm whether that threshold for mushrooms has changed.
  • Spain: according to Energy Control, possessing spores is not an offence, but once a spore has become a mushroom it is treated as a drug.

This is not legal advice

This overview describes the general legal situation in ten countries as of October 2026, based on the sources listed below the article. It is not legal advice, and the interpretation of these laws can change through new legislation or court rulings. Before you buy, carry or ship anything, check the official legal texts of the country you live in or travel to, or ask a lawyer. Mondo’s terms state that customers are responsible for checking whether products are legal in their country.

What does the research say?

Psilocybin is one of the most studied psychedelics in psychiatry, mainly for depression that has not responded to standard treatment. In a phase 2b trial with 233 participants, a single session with synthetic psilocybin and psychological support reduced depressive symptoms more than a very low control dose after three weeks (Goodwin et al., 2022, New England Journal of Medicine). In July 2026 Compass Pathways reported that its psilocybin product COMP360 met the primary endpoint in a second phase 3 trial with 581 participants and said it expects to complete its US application in the fourth quarter of 2026.

These are clinical products given under medical supervision, with screening and therapists present. The results do not apply to mushrooms used on your own.

Psilocybin therapy in Europe in 2026

  • EU level: the EUDA wrote in 2024 that no classical psychedelic had been approved at member-state or EU level. As far as we could verify in October 2026, no psilocybin medicine holds an EU marketing authorisation.
  • Czechia: Act 270/2025 Sb. took effect on 1 January 2026 and allows therapeutic psilocybin in specialised healthcare facilities, the first such law in the EU. The National Institute of Mental Health stated that treatment was not yet available and was expected to start in the second half of 2026, once reimbursement rules are settled.
  • Germany: the federal medicines agency BfArM approved a compassionate use programme in July 2025 for treatment-resistant depression at two clinics, in Mannheim and Berlin.
  • Switzerland: since 2014 the Federal Office of Public Health has granted exemptions for limited medical use. It issued 322 psilocybin exemptions in 2024, according to a report commissioned by the BAG.
  • Netherlands: psilocybin therapy is still limited to research in 2026, according to the Trimbos Institute. The government and ZonMw made €2.6 million available in 2024 for research into therapeutic uses of psychedelics, including psilocybin.

Growing magic mushrooms as a hobby

Many people get into mycology through cultivation: watching mycelium colonise a substrate and fruit is a lesson in biology you can follow day by day. Where it is legal, there are three common ways to start.

OptionWhat it isSuited to
Grow kitA ready-colonised substrate of Psilocybe cubensis (750, 1200 or 2100 cc) that only needs the right humidity and temperatureBeginners who want a predictable start
Spore or liquid culture syringeSpores or living mycelium in a 20 ml syringe, for microscopy or for growing your own substrateHobbyists who want to learn the full process
Magic trufflesFresh sclerotia, sold where the law allows itPeople in the Netherlands, where fresh truffles are not covered by the Opium Act

Mondo has produced its grow kits in the Netherlands since 2009. You can start with a magic mushroom grow kit and follow the grow kit manual, or go one step further with Psilocybe cubensis spore syringes and liquid culture syringes. Check the table above before ordering: in several countries spores and kits are legal, but growing mushrooms from them is not.

Grow kits from Mondo

✓Growing since 2009✓Discreet, tracked shipping✓Step-by-step manuals

Every Mondo product comes with a step-by-step manual on our site, and orders ship discreetly with tracking.

More questions about magic mushrooms

Stay with the person, move to a quiet and familiar place and keep reassuring them that the effects will pass. Do not leave them alone. Call 112 if they are a danger to themselves or others, or if they seem physically unwell.

Psilocybin has low physical toxicity, so a fatal overdose from psilocybin alone is rare. The bigger dangers are psychological crises, accidents during the experience and poisoning from misidentified wild mushrooms. Mixing with other substances raises the risk.

Psilocybin is not considered physically addictive, and tolerance builds within days, which reduces the effect of repeated use. Psychological reliance is possible, as with any substance used to cope with problems.

A grow kit contains mycelium and substrate but no mushrooms yet, and some laws only name the mushrooms or their active compounds. Other countries, Germany for example, also cover spores and mycelium if they are meant for growing psychoactive mushrooms.

Dutch law only covers what happens in the Netherlands. Once you cross a border, the law of that country applies, and in most European countries truffles are treated as a psilocybin product and are illegal.

The rating of www.mondogrowkits.com at WebwinkelKeur Reviews is 4,6/5 based on 586 reviews.